Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option
NAV
₹31.3551
as of 2026-10-12
Price History (NAV)
Performance Metrics (3 Year)
3Y CAGR
16%
Category avg 17.9%
Fund size
₹883 Cr
Assets under management
Sharpe
0.79
Risk-adjusted return (3Y)
Max drawdown
6.0%
Peak-to-trough decline (3Y)
Beta
0.78
Market sensitivity (3Y)
SIP / returns estimator
Estimation is based on the past performance of this fund
Total Corpus After 7 Year(s)
@12.0% p.a. returns
₹4.20 L
+₹2.40 L
Fund FAQs
Frequently asked questions about Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option
Answers use the latest facts on this page and Qonfido’s peer-group tiers. They are research aids, not personalised investment advice. How ratings work
What is the NAV of Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option today?
As of 2026-10-12, the NAV of Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option shown on Qonfido is ₹31.3551. Mutual fund NAVs are typically published for each market day; always check the as-of date before acting.
Is Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option a good fund?
Qonfido currently places Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option in the Standard tier within the Healthcare Fund peer group. Standard tier means the fund is broadly in line with category peers on Qonfido’s scorecard. This is a peer-group research signal—not a buy recommendation, suitability assessment, or guarantee of future returns. See Qonfido’s fund rating methodology for how tiers are built and their limits.
Is Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option a good fit for me?
Whether Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option is a good fit depends on your goals, risk tolerance, time horizon, tax situation, and the rest of your portfolio—not on a single fund page. Qonfido does not provide personalised SEBI-registered investment advice here. Use AI Fund Discovery to explore alternatives, or consult a licensed advisor for suitability.
What is the 3-year return of Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option?
The 3-year CAGR shown for Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option on Qonfido is 15.8% (category average about 17.9% for Healthcare Fund where available). Past performance is not indicative of future results and does not mean the fund is suitable for you.
Which category does Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option belong to?
Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option is a Healthcare Fund scheme from Tata Mutual Fund. Explore the Healthcare Fund category page on Qonfido to compare peers within the same SEBI group.
How can I explore Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option further on Qonfido?
Reported fund size (AUM) for Tata India Pharma & Healthcare Fund - Regular Plan - Growth Option is about ₹883 Cr. AUM is context only and does not predict returns. On Qonfido you can review the fact card, open related best-fund categories, try the SIP calculator with this scheme, or ask AI Fund Discovery for peer comparisons—still as research support, not personalised advice.
Similar Funds in Healthcare Fund
Explore Tata Mutual Fund
See schemes, AUM, Qonfido Premier picks, and ask Qonfido about this fund house.